Cytomx Therapeutics Inc Asset Turnover Ratio (CTMX), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cytomx Therapeutics Inc   (NASDAQ: CTMX)
 

Cytomx Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the first quarter 2026, Cytomx Therapeutics Inc 's asset turnover ratio sequentially decreased to 0.17 in the first quarter (Mar 31 2026), this is lower than usual.

Within sector 135 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2026 compared to the preceding quarter from 1752 to 2399.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CTMX Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change 264.84 % 25.75 % 13.87 % 9.95 % -46.67 %
Y / Y Revenue Change -79.85 % -98.26 % -82.16 % -25.71 % 22.8 %
Asset Turnover Ratio (TTM) 0.17 0.52 0.82 1.06 1.14
CTMX's Total Ranking # 2399 # 1752 # 246 # 704 # 233
Seq. Asset Change 137.1 % -4.23 % -9.6 % 77.73 % -18.28 %
Seq. Revenue Change 1447.21 % -88.88 % -68.04 % -63.36 % 33.66 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 136
Healthcare Sector # 408
Overall Market # 2399

Asset Turnover Ratio Statistics
High Average Low
1.14 0.33 0.1
(Mar 31 2025)   (Dec 31 2021)




CTMX Company Profile • Back to CTMX Efficiency Comparisons • Compare CTMX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Zomedica Corp   0.27 $ 34.660  Millions$ 128.987  Millions
Fulgent Genetics Inc   0.27 $ 319.019  Millions$ 1,196.074  Millions
Repligen Corp  0.26 $ 763.339  Millions$ 2,926.452  Millions
Adc Therapeutics Sa  0.26 $ 79.175  Millions$ 306.491  Millions
Neogen Corporation  0.26 $ 871.509  Millions$ 3,385.236  Millions
Bio rad Laboratories Inc   0.26 $ 2,589.300  Millions$ 10,069.250  Millions
Teleflex Incorporated  0.25 $ 1,838.287  Millions$ 7,244.350  Millions
Innoviva Inc   0.25 $ 394.185  Millions$ 1,558.608  Millions
Maravai Lifesciences Holdings Inc   0.25 $ 203.841  Millions$ 807.488  Millions
Retractable Technologies Inc  0.25 $ 36.180  Millions$ 143.438  Millions
Biolife Solutions Inc   0.25 $ 99.673  Millions$ 396.528  Millions
Opus Genetics Inc   0.25 $ 11.983  Millions$ 47.954  Millions
Hcw Biologics Inc   0.25 $ 6.592  Millions$ 26.554  Millions
Keenova Therapeutics Plc  0.25 $ 1,413.000  Millions$ 5,720.150  Millions
Theravance Biopharma inc   0.24 $ 109.775  Millions$ 449.845  Millions
Revvity Inc  0.24 $ 2,902.407  Millions$ 12,166.686  Millions
Cryoport inc   0.24 $ 182.935  Millions$ 769.213  Millions
Verastem Inc   0.23 $ 49.585  Millions$ 211.842  Millions
Nuvation Bio Inc   0.23 $ 142.121  Millions$ 613.462  Millions
Enanta Pharmaceuticals Inc  0.23 $ 69.213  Millions$ 306.492  Millions
Arcus Biosciences Inc   0.23 $ 236.000  Millions$ 1,046.250  Millions
Precigen Inc   0.22 $ 31.595  Millions$ 141.823  Millions
Personalis Inc   0.22 $ 64.515  Millions$ 290.270  Millions
Nutriband Inc   0.22 $ 1.803  Millions$ 8.259  Millions
Marker Therapeutics inc   0.22 $ 3.949  Millions$ 18.252  Millions
Editas Medicine Inc   0.21 $ 38.693  Millions$ 187.051  Millions
Wave Life Sciences Ltd   0.21 $ 88.173  Millions$ 428.944  Millions
Pacific Biosciences Of California Inc   0.20 $ 159.992  Millions$ 798.769  Millions
Zymeworks Inc   0.20 $ 81.263  Millions$ 407.599  Millions
Ligand Pharmaceuticals Incorporated  0.20 $ 274.476  Millions$ 1,379.530  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.